Viewing data from:

THYRO-BLOCK

NDA

POTASSIUM IODIDE | N018307 | MEDA PHARMACEUTICALS

1 strength0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

API Supply Chain3 active DMFs2 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

MERCK KGAAPOTASSIUM IODIDE

DMF 236152010

PROTO CHEMICAL INDUSTRIESPOTASSIUM IODIDE IP/BP/USP

DMF 321312017

SAMRAT PHARMACHEM LTDPOTASSIUM IODIDE USP

DMF 424182025

AJAY CHEMICALS INCInactivePOTASSIUM IODIDE USP

DMF 57801985

MALLINCKRODT INCInactivePOTASSIUM IODIDE USP GRANULAR FOOD GRADE, CODE 1112 AND POTASSIUM IODIDE BP IODURE DE POTASSIUM, CODE 1220

DMF 160502002

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 130MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.